SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-022137
Filing Date
2020-02-14
Accepted
2020-02-14 21:28:22
Documents
1
Period of Report
2020-02-10

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3486
  Complete submission text file 0001104659-20-022137.txt   4856
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Issuer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O STEMLINE THERAPEUTICS, INC. 750 LEXINGTON AVENUE, 6TH FLOOR NEW YORK NY 10022
Business Address
Bergstein Ivan (Reporting) CIK: 0001554767 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35619 | Film No.: 20623079